141 related articles for article (PubMed ID: 2422087)
1. [Occurrence of increased alpha-fetoprotein in non-neoplastic hepatopathies of alcoholic or non-alcoholic origin].
Pol S; Nalpas B; Bezeaud A; Bréchot C; Berthelot P
Gastroenterol Clin Biol; 1986 Feb; 10(2):112-6. PubMed ID: 2422087
[TBL] [Abstract][Full Text] [Related]
2. [Markers of the hepatitis B virus and chronic alcoholism. Prevalence and risk factors].
Renard P; Hillon P; Bedenne L; Fourot M; Milan C; Faivre J; Klepping C
Ann Gastroenterol Hepatol (Paris); 1991; 27(1):7-12. PubMed ID: 1851406
[TBL] [Abstract][Full Text] [Related]
3. [Relation between serum markers of hepatitis B virus and alpha fetoprotein in hepatocellular carcinoma in France].
Attali P; Prod'homme S; Pelletier G; Papoz L; Buffet C; Etienne JP
Gastroenterol Clin Biol; 1986 Oct; 10(10):637-40. PubMed ID: 2431948
[TBL] [Abstract][Full Text] [Related]
4. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
[TBL] [Abstract][Full Text] [Related]
5. Alpha-fetoprotein in hepatitis superimposed on cirrhosis: a case of concomitant hepatitis B surface antigen and antibody associated with a major but transient increase in the alpha-fetoprotein level.
Bergmann JF; Lang F; Dechy H; Dorra M
Am J Gastroenterol; 1985 Oct; 80(10):810-2. PubMed ID: 2412436
[TBL] [Abstract][Full Text] [Related]
6. [Prevalence of HLA-A and -B antigens, anti-HBc and -HBs antibodies in alcoholic hepatopathies].
Doffoël M; Tongio MM; Ledig M; Charrault A; Vetter D; North ML; Mayer S; Mandel P; Bockel R
Ann Med Interne (Paris); 1985; 136(3):225-8. PubMed ID: 3875304
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus serological markers in Africans with liver cirrhosis and hepatocellular carcinoma.
Coursaget P; Chiron JP; Barres JL; Barin F; Cottey P; Tortey E; Yvonnet B; Diop B; MBoup S; Diop-Mar I
IARC Sci Publ; 1984; (63):181-98. PubMed ID: 6085625
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological features of hepatocellular carcinoma--comparison of hepatitis B seropositive and seronegative patients.
Okuda H; Obata H; Motoike Y; Hisamitsu T
Hepatogastroenterology; 1984 Apr; 31(2):64-8. PubMed ID: 6202615
[TBL] [Abstract][Full Text] [Related]
9. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
10. Serologic studies of hepatitis viruses for their aetiologic role in chronic liver disease.
Pár A; Hollós I; Bajtai G; Ambrus M; Barna K; Kovács M; Jávor T
Acta Med Acad Sci Hung; 1980; 37(1):1-15. PubMed ID: 7457011
[TBL] [Abstract][Full Text] [Related]
11. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation].
Bujanda L; García Bengoechea M; Cilla G; Gil I; yArenas JI
Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540
[TBL] [Abstract][Full Text] [Related]
12. The detection of alpha-fetoprotein in HBs Ag and HBe Ag carriers.
Panoyotopoulos S; Yiannacopoulos T; Margari-Papanicolaou P; Christou A
Allergol Immunopathol (Madr); 1982; 10(1):1-4. PubMed ID: 6177229
[TBL] [Abstract][Full Text] [Related]
13. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic].
Petry W; Heintges T; Hensel F; Erhardt A; Wenning M; Niederau C; Häussinger D
Z Gastroenterol; 1997 Dec; 35(12):1059-67. PubMed ID: 9487638
[TBL] [Abstract][Full Text] [Related]
14. Relationship of hepatitis B antigen in cirrhosis and hepatoma in Thailand. An etiological significance.
Chanuvati T; Viranuvatti V; Pongpipat D
Gastroenterology; 1975 May; 68(5 Pt 1):1261-4. PubMed ID: 47828
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of elevated alpha-fetoprotein (AFP) in chronic hepatitis C without hepatocellular carcinoma.
Chen CH; Lin ST; Kuo CL; Nien CK
Hepatogastroenterology; 2008; 55(85):1423-7. PubMed ID: 18795704
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and etiologic features of hepatocarcinoma in Sicily].
Carroccio A; Soresi M; Bonfissuto G; Magliarisi C; Anastasi G; Vuturo O; Notarbartolo A; Montalto G
Ann Ital Med Int; 1999; 14(4):233-8. PubMed ID: 10638015
[TBL] [Abstract][Full Text] [Related]
17. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
Hong WS; Hong SI; Park SY; Son Y; Lee YS; Chung YH; Yang SK; Suh DJ; Min YI
Anticancer Res; 1995; 15(6B):2777-80. PubMed ID: 8669863
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B viral markers in patients with primary hepatocellular carcinoma in Taiwan.
Chien MC; Tong MJ; Lo KJ; Lee JK; Milich DR; Vyas GN; Murphy BL
J Natl Cancer Inst; 1981 Mar; 66(3):475-9. PubMed ID: 6162990
[TBL] [Abstract][Full Text] [Related]
19. Assessment of alpha-fetoprotein in chronic HBsAg carriers and in HBsAg negative cirrhosis of the liver.
Stránský J; Zichová M; Vodák M
Sb Lek; 1993; 94(4):311-5. PubMed ID: 7527585
[TBL] [Abstract][Full Text] [Related]
20. Clinical implications of alpha-fetoprotein in liver cirrhosis: five-year follow-up study.
Harada T; Shigeta K; Noda K; Fukumoto Y; Nishimura H; Mizuta M; Takemoto T
Hepatogastroenterology; 1980 Jun; 27(3):169-75. PubMed ID: 6161869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
